As a result, we found a high expression level of DDIT4 associated with the worse overall survival (OS) (HR (high) = 1.5, P (HR) = 0.037) in PAAD patients (Fig. 1B). This evidence concerns the gene DDIT4 and pancreatic adenocarcinoma.